Page last updated: 2024-11-05

urapidil and Liver Failure, Acute

urapidil has been researched along with Liver Failure, Acute in 1 studies

Liver Failure, Acute: A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.

Research Excerpts

ExcerptRelevanceReference
"Dihydralazine increases nutritive portal and hepatic microvascular flow and limits liver injury after hemorrhagic shock."7.73Dihydralazine treatment limits liver injury after hemorrhagic shock in rats. ( Baechle, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pannen, BH; Roesslein, M; Schmidt, R, 2006)
"Dihydralazine increases nutritive portal and hepatic microvascular flow and limits liver injury after hemorrhagic shock."3.73Dihydralazine treatment limits liver injury after hemorrhagic shock in rats. ( Baechle, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pannen, BH; Roesslein, M; Schmidt, R, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schmidt, R1
Baechle, T1
Hoetzel, A1
Loop, T1
Humar, M1
Roesslein, M1
Geiger, KK1
Pannen, BH1

Other Studies

1 other study available for urapidil and Liver Failure, Acute

ArticleYear
Dihydralazine treatment limits liver injury after hemorrhagic shock in rats.
    Critical care medicine, 2006, Volume: 34, Issue:3

    Topics: Analysis of Variance; Animals; Antihypertensive Agents; Dihydralazine; Heme Oxygenase-1; Hemodynamic

2006